Literature DB >> 7473264

Detection of cytomegalovirus and Epstein-Barr virus in labial salivary glands in Sjogren's syndrome and non-specific sialadenitis.

N Maitland1, S Flint, C Scully, S J Crean.   

Abstract

To investigate the role of herpes viruses in Sjogren's syndrome, minor (labial) salivary gland tissues from Sjogren's syndrome and from non-specific sialadenitis were examined for Epstein-Barr virus (EBV) and human cytomegalovirus (HCMV) DNA by the polymerase chain reaction. Almost half of all salivary glands studied contained EBV and/or HCMV. There was, however, no significant difference between the detection of EBV or HCMV in salivary glands from patients with Sjogren's syndrome or non-specific sialadenitis. The findings are consistent with the persistence of EBV and HCMV in minor salivary glands following primary infection, but do not indicate a direct role for either virus in the aetiology of Sjogren's syndrome, and do not exclude reactivation of the viruses in this disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473264      PMCID: PMC7166772          DOI: 10.1111/j.1600-0714.1995.tb01187.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  43 in total

1.  Possible involvement of Epstein-Barr virus (EBV) in polyclonal B-cell activation in Sjögren's syndrome.

Authors:  N Miyasaka; K Yamaoka; M Tateishi; K Nishioka; K Yamamoto
Journal:  J Autoimmun       Date:  1989-08       Impact factor: 7.094

2.  Comparison of the immune response to Epstein-Barr virus and cytomegalovirus in sera and synovial fluids of patients with rheumatoid arthritis.

Authors:  M Musiani; M Zerbini; S Ferri; M Plazzi; G Gentilomi; M La Placa
Journal:  Ann Rheum Dis       Date:  1987-11       Impact factor: 19.103

3.  Primary Sjögren's syndrome after infectious mononucleosis.

Authors:  S Whittingham; J McNeilage; I R Mackay
Journal:  Ann Intern Med       Date:  1985-04       Impact factor: 25.391

4.  Parotid gland enlargement and xerostomia associated with labial sialadenitis in HIV-infected patients.

Authors:  M Schiødt; D Greenspan; T E Daniels; J Nelson; P J Leggott; D W Wara; J S Greenspan
Journal:  J Autoimmun       Date:  1989-08       Impact factor: 7.094

5.  T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome.

Authors:  J C Vernant; G Buisson; J Magdeleine; J De Thore; A Jouannelle; C Neisson-Vernant; N Monplaisir
Journal:  Lancet       Date:  1988-01-23       Impact factor: 79.321

6.  Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren's syndrome.

Authors:  W G Shattles; S M Brookes; P J Venables; D A Clark; R N Maini
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

7.  Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy).

Authors:  N Talal; M J Dauphinée; H Dang; S S Alexander; D J Hart; R F Garry
Journal:  Arthritis Rheum       Date:  1990-06

8.  Detection of human papilloma virus type 16 DNA in oral squames from normal young adults.

Authors:  H Jalal; C M Sanders; S S Prime; C Scully; N J Maitland
Journal:  J Oral Pathol Med       Date:  1992-11       Impact factor: 4.253

9.  Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.

Authors:  K Terada; S Katamine; K Eguchi; R Moriuchi; M Kita; H Shimada; I Yamashita; K Iwata; Y Tsuji; S Nagataki
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

10.  Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis.

Authors:  R I Fox; M Luppi; P Pisa; H I Kang
Journal:  J Rheumatol Suppl       Date:  1992-01
View more
  9 in total

1.  Massive cutaneous follicular lymphoid hyperplasia in a patient with the Sjögren syndrome: 7-year follow-up and immunohistochemical study.

Authors:  Yasuhiro Horiuchi; Junichi Hakugawa; Kazuhiro Shimizu; Ichiro Katayama; Tomayoshi Hayashi; Masahiro Kikuchi
Journal:  Rheumatol Int       Date:  2006-04-20       Impact factor: 2.631

2.  Investigation into a possible association between oral lichen planus, the human herpesviruses, and the human papillomaviruses.

Authors:  Cathal OFlatharta; Stephen R Flint; Mary Toner; David Butler; Mohamed J E M F Mabruk
Journal:  Mol Diagn       Date:  2003

Review 3.  Persistent viral infection in primary Sjogren's syndrome: review and perspectives.

Authors:  Antigoni Triantafyllopoulou; Haralampos Moutsopoulos
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 4.  Herpesvirus-bacteria synergistic interaction in periodontitis.

Authors:  Casey Chen; Pinghui Feng; Jørgen Slots
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

Review 5.  Viruses and salivary gland disease (SGD): lessons from HIV SGD.

Authors:  L Jeffers; J Y Webster-Cyriaque
Journal:  Adv Dent Res       Date:  2011-04

6.  Natural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease.

Authors:  Virginia A Carroll; Alyssa Lundgren; Hairong Wei; Susan Sainz; Kenneth S Tung; Michael G Brown
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 7.  Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren's Syndrome: Promising Inhibitory Effect of IL-37.

Authors:  Pio Conti; Luisa Stellin; Alesssandro Caraffa; Carla E Gallenga; Rhiannon Ross; Spyros K Kritas; Ilias Frydas; Ali Younes; Paolo Di Emidio; Gianpaolo Ronconi
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

8.  Targeting the Ca(2+) Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome.

Authors:  Alessia Gallo; Shyh-Ing Jang; Hwei Ling Ong; Paola Perez; Mayank Tandon; Indu Ambudkar; Gabor Illei; Ilias Alevizos
Journal:  EBioMedicine       Date:  2016-06-29       Impact factor: 8.143

Review 9.  Role of Viral Infections in the Pathogenesis of Sjögren's Syndrome: Different Characteristics of Epstein-Barr Virus and HTLV-1.

Authors:  Hideki Nakamura; Toshimasa Shimizu; Atsushi Kawakami
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.